Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.
| MER Indicator |
MER description |
Target Fiscal Year |
Target |
| C2.1.D |
Number of HIV-positive individuals receiving a minimum of one clinical service |
2015 |
13,575 |
| C2.4.D |
Number of HIV-positive individuals receiving a minimum of one clinical service |
2015 |
13,575 |
| C2.4.D |
Number of HIV-positive patients who were screened for TB in HIV care or treatment setting |
2015 |
13,575 |
| C2.5.D |
Number of HIV-positive individuals receiving a minimum of one clinical service |
2015 |
13,575 |
| C2.5.D |
Number of HIV-positive patients in HIV care who started TB treatment |
2015 |
458 |
| CARE_NEW |
Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load |
2015 |
2,189 |
| FPINT_SITE |
Number of service delivery points supported by PEPFAR for HIV services that are directly providing integrated voluntary family planning services |
2015 |
11 |
| FPINT_SITE |
Total number of PEPFAR-supported HIV service delivery points: PMTCT, Care and Treatment |
2015 |
14 |
| GEND_GBV |
By PEP service provision (related to sexual violence services provided) |
2015 |
130 |
| GEND_GBV |
By type of service: Sexual Violence (Post-Rape Care) |
2015 |
140 |
| GEND_GBV |
Number of people receiving post-GBV care |
2015 |
140 |
| GEND_GBV |
Sex: Female |
2015 |
138 |
| GEND_GBV |
Sex: Male |
2015 |
2 |
| GEND_GBV |
Sum of Sex disaggregates |
2015 |
140 |
| HTS_TST |
By Test Result: Negative |
2015 |
112,956 |
| HTS_TST |
Number of individuals who received T&C services for HIV and received their test results during the past 12 months |
2015 |
117,454 |
| HTS_TST |
Sum of Test Result disaggregates |
2015 |
117,454 |
| HTS_TST_POS |
By Test Result: Positive |
2015 |
4,498 |
| OVC_SERV |
Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS |
2015 |
9,000 |
| PMTCT_ARV |
Life-long ART (including Option B+) |
2015 |
650 |
| PMTCT_ARV |
Maternal triple ARV prophylaxis (provided with the intention to stop at the end of the breastfeeding period) |
2015 |
110 |
| PMTCT_ARV |
Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) |
2015 |
825 |
| PMTCT_ARV |
Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery |
2015 |
760 |
| PMTCT_ARV |
Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy |
2015 |
212 |
| PMTCT_ARV |
Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy |
2015 |
438 |
| PMTCT_ARV |
Sum of New and Current disaggregates |
2015 |
650 |
| PMTCT_ARV |
Sum of Regimen Type disaggregates |
2015 |
760 |
| PMTCT_EID |
Number of HIV- positive pregnant women identified during the reporting period (include known HIV-positive women at entry into PMTCT) |
2015 |
825 |
| PMTCT_EID |
Number of infants who had a virologic HIV test within 12 months of birth during the reporting period |
2015 |
627 |
| PMTCT_SITE |
Number of PEPFAR-supported sites achieving 90% ARV or ART coverage for HIV+ pregnant women |
2015 |
7 |
| PMTCT_SITE |
Total number of PEPFAR supported sites providing PMTCT services (HTC and ARV or ART services) |
2015 |
13 |
| PMTCT_STAT |
Number of new ANC and L&D clients |
2015 |
34,366 |
| PMTCT_STAT |
Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) |
2015 |
31,242 |
| QI_SITE |
Number of PEPFAR-supported clinical service sites with a quality improvement activity completed that addresses clinical HIV programs and has documented process results in the last 6 months |
2015 |
14 |
| QI_SITE |
Total number of PEPFAR-supported sites for any HIV clinical service including HIV Care, HIV Treatment, TB care, PMTCT, VMMC, and HTC |
2015 |
14 |
| SITE_SUPP |
By program area/support type: Care and Support Direct Service Delivery (DSD) |
2015 |
13 |
| SITE_SUPP |
By program area/support type: PMTCT Direct Service Delivery (DSD) |
2015 |
13 |
| SITE_SUPP |
By program area/support type: TB/HIV Direct Service Delivery (DSD) |
2015 |
13 |
| SITE_SUPP |
By program area/support type: Treatment Direct Service Delivery (DSD) |
2015 |
12 |
| SITE_SUPP |
Number of unique sites supported by PEPFAR |
2015 |
14 |
| TB_ART |
The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period |
2015 |
458 |
| TB_SCREEN |
The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period |
2015 |
13,575 |
| TX_CURR |
Number of adults and children receiving antiretroviral therapy (ART) |
2015 |
10,922 |
| TX_NEW |
Number of adults and children newly enrolled on antiretroviral therapy (ART) |
2015 |
2,915 |
| TX_RET |
Number of adults and children who are still alive and on treatment at 12 months after initiating ART |
2015 |
2,309 |
| TX_RET |
Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up |
2015 |
2,886 |
